by [email protected] | May 5, 2023 | Hematology, Publication
Abstract Background: This study retrospectively compared annualized billed bleed rates (ABRb) in people with hemophilia A (PwHA) without inhibitors who switched from factor VIII (FVIII) prophylaxis to emicizumab. Research design and methods: A real-world comparison...
by [email protected] | Mar 14, 2023 | Infectious Disease, Publication
Abstract Objectives The only available oral pre-exposure prophylaxis (PrEP) regimens approved in the United States to prevent HIV infection during the period covered by this study were emtricitabine/tenofovir alafenamide (F/TAF) and emtricitabine/tenofovir...
by [email protected] | Feb 16, 2023 | Endocrine, Publication
Abstract Aims To identify patient clusters with poor glucose control among type 2 diabetes mellitus (T2DM) patients with obesity who are receiving basal-bolus insulin and to identify the potential therapeutic inertia factors associated with poor control. Methods...
by [email protected] | Feb 14, 2023 | Cancer (blood), Hematology, Oncology, Publication
ABSTRACT Background: Primary myelofibrosis [PMF] is a myeloproliferative neoplasm associated with reduced overall survival (OS). Management strategies for PMF have evolved over the last two decades, including approval of ruxolitinib as the first Janus kinase 1...
by [email protected] | Feb 14, 2023 | immunology, Publication
Abstract Objective: Assess healthcare costs associated with systemic lupus erythematosus (SLE) flares among patients with and without lupus nephritis (LN). Methods: This retrospective cohort study used medical and pharmacy claims data from the United...
by [email protected] | Jan 13, 2023 | Cardiovascular, Publication
Abstract Background: In the USA, there is a steady rise of atrial fibrillation due to the aging population with increased morbidity. This study evaluated the risk of stroke/systemic embolism (S/SE) and major bleeding (MB) among elderly patients with...
